Since the first approved gene therapy trial in 1990, interest in cell and gene therapies has increased rapidly, changing the course of research on disease prevention and treatment. However, there are still many challenges facing the field today, and further progress to be made in developing effective therapies.
The Advancing CGT Virtual Event is a free, 2-day meeting presented by GENEWIZ and Brooks Life Sciences, offering a platform for industry leaders and researchers from across the globe to discuss the opportunities, challenges, and latest breakthroughs in cell and gene therapy. Attendees will have the opportunity to learn more about various topics, such as developing AAV-based gene therapies, cold chain products and solutions for a wide range of materials, and more, as well as explore innovative solutions to accelerate the therapeutic development and safe delivery of successful cell and gene therapies.
By registering for the event, attendees can:
Use the official event hashtag #AdvCGT21 to join the conversation and stay up to date on the latest event information
Senior Scientist, Kuopio Center for Gene and Cell Therapy
Chief Technology Officer, Pluristyx, Inc.
Supervisor, Technical Applications, GENEWIZ, A Brooks Life Sciences Company
Technical Application Scientist, GENEWIZ, A Brooks Life Sciences Company
Science and Technology Advisor, 10x Genomics
Field Applications Manager, AMR East for Pacific Biosciences